Drug Delivery Devices Market To Reach $841.4 Billion By 2033

Drug Delivery Devices Market Growth & Trends

The global drug delivery devices market size is estimated to reach USD 841.4 billion by 2033, expanding at a CAGR of 7.8% from 2026 to 2033, according to a new report by Grand View Research, Inc. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market.

Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.

Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.

 Request a free sample copy or view report summary: Drug Delivery Devices Market Report

Drug Delivery Devices Market Report Highlights

• The inhalers segment leads the market with a share of 23.9% in 2025, driven by the demand for asthma treatment. However, conventional metered-dose inhalers contribute significantly to greenhouse gas emissions.

• The drug delivery devices segment for diabetes dominated the market in 2025 with a share of 21.0%.

• The hospitals segment held the largest market share in 2025 with a share of 28.9%, driven by the rising demand for surgical interventions and preventive procedures.

• The North America drug delivery devices market dominated the overall global market and accounted for the 32.4% revenue share in 2025.

Drug Delivery Devices Market Segmentation

Grand View Research has segmented the global drug delivery devices market based on product, application, end use, and region:

Drug Delivery Devices Product Outlook (Revenue, USD Million, 2021 - 2033)

• Inhalers

  • Metered-dose inhalers (MDIs)

  • Dry powder inhalers (DPIs)

  • Others

• Injection Devices

  • Prefilled Syringes

  • Auto-injectors

  • Pen injectors

  • Needle-free injectors

  • Wearable injectors

• Implants

  • Contraceptive implants

  • Drug-eluting stents

  • Biodegradable implants

• Topical Delivery System

  • Creams

  • Gels

  • Ointments

• Oral Delivery System

  • Controlled-release tablets and capsules

  • Buccal and sublingual tablets

• Occular Delivery System

• Nebulizers

• Transdermal Patches

• Infusion Pumps

Drug Delivery Devices Application Outlook (Revenue, USD Million, 2021 - 2033)

• Oncology

• Infectious Diseases

• Respiratory Diseases

• Diabetes

• Cardiovascular Diseases

• Autoimmune Diseases

• Central Nervous System Disorders

• Others

Drug Delivery Devices End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Hospitals

• Diagnostic Centers

• Ambulatory Surgery Centers/Clinics

• Home Care Settings

• Others

Drug Delivery Devices Region Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Drug Delivery Devicesy Market

• Gerresheimer AG

• W. L. Gore & Associates, Inc.

• Abbott

• Terumo Medical Corporation

• Stryker

• Medtronic

• Boston Scientific Corporation

• Novartis AG

• Becton, Dickinson and Company

• Teleflex Incorporated